HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Townsend-Nicholson, A. Articles by Schofield, P. R. Search for Related Content PubMed PubMed Citation Articles by Townsend-Nicholson, A. Articles by Schofield, P. R. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 4, 2373-2376, 01, 1994

A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding

A Townsend-Nicholson and PR Schofield
Garvan Institute of Medical Research, Darlinghurst, New South Wales, Sydney, Australia.

The A1 adenosine receptor is a member of the seven-transmembrane G protein-coupled, receptor superfamily. This receptor binds the purine nucleoside adenosine with high affinity and inhibits the activity of adenylate cyclase. We have used site-directed mutagenesis and functional expression studies to examine the role of the threonine residue, located at position 277 in transmembrane domain VII of the human A1 receptor. Mutation of Thr-277 to either serine or alanine resulted in the expression of receptors that had essentially no change in binding affinity for the A1 selective antagonist 8-cyclo-pentyl-1,3- dipropylxanthine. Mutation of Thr-277 to serine resulted in modest (4.4- 8.6-fold) but significant increases in the observed Ki values for three adenosine agonists, namely N-(1-methyl-2-phenethyl)adenosine (R-PIA or S-PIA) and 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-L- ribofuranuronamide) (NECA). However, mutation of Thr-277 to alanine resulted in no significant changes in the Ki for R-PIA or S-PIA but did result in a highly significant 437-fold increase in the Ki for NECA. This demonstrates that the hydroxyl moiety of Thr-277 mediates agonist but not antagonist binding and, more specifically, that this residue forms a probable molecular contact site with the 5' substitution found in NECA.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein J. Biol. Chem., September 15, 2006; 281(37): 26951 - 26965. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				E. S. Dawson and J. N. Wells Determination of Amino Acid Residues that are Accessible from the Ligand Binding Crevice in the Seventh Transmembrane-Spanning Region of the Human A1 Adenosine Receptor Mol. Pharmacol., April 16, 2001; 59(5): 1187 - 1195. [Abstract] [Full Text]

				S. A. Rivkees, H. Barbhaiya, and A. P. IJzerman Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor J. Biol. Chem., February 5, 1999; 274(6): 3617 - 3621. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				Q. Jiang, D. Guo, B. X. Lee, A. M. Van Rhee, Y.-C. Kim, R. A. Nicholas, J. B. Schachter, T. K. Harden, and K. A. Jacobson A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor Mol. Pharmacol., September 1, 1997; 52(3): 499 - 507. [Abstract] [Full Text]

				S. A. Rivkees, M. E. Lasbury, and H. Barbhaiya Identification of Domains of the Human A(1) Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A(1)/A[IMAGE] Adenosine Receptors J. Biol. Chem., September 1, 1995; 270(35): 20485 - 20490. [Abstract] [Full Text] [PDF]

				J. Kim, Jür. Wess, A. M. v. Rhee, T. Schöneberg, and K. A. Jacobson Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A[IMAGE] Adenosine Receptor J. Biol. Chem., June 9, 1995; 270(23): 13987 - 13997. [Abstract] [Full Text] [PDF]